Cargando…

Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast Cancer Patients without Diabetes

PURPOSE: Breast cancer treatments, including chemotherapy, administered in combination with glucocorticoids can induce hyperglycemia. This study aimed to investigate the effect of hyperglycemia during adjuvant chemotherapy on the prognosis of breast cancer patients without a known history of diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Ha Rim, Kang, Sang Yull, Youn, Hyun Jo, Jung, Sung Hoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462816/ https://www.ncbi.nlm.nih.gov/pubmed/32908790 http://dx.doi.org/10.4048/jbc.2020.23.e44

Ejemplares similares

Risk factor for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma
por: Ahn, Ha Rim, et al.
Publicado: (2020)

The prognosis of NX stage in patients with pT1 papillary thyroid cancer who underwent lobectomy
por: Ahn, Ha Rim, et al.
Publicado: (2023)

Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
por: Mahin, Dana, et al.
Publicado: (2023)

PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy
por: Cho, Yoon Ah, et al.
Publicado: (2022)

Downregulation of matriptase suppresses the PAR-2/PLCγ2/PKC-mediated invasion and migration abilities of MCF-7 breast cancer cells
por: Kim, Jeong-Mi, et al.
Publicado: (2021)

Invited Commentary: Role of Estrogen Receptor-α in Regulating Claudin-6 Expression in Breast Cancer Cells
por: Youn, Hyun Jo, et al.
Publicado: (2011)

Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA-induced breast cancer cell invasion via PLCγ2/PKCβ/NF-κB/AP-1-dependent matrix metalloproteinase-9 activation
por: Kim, Jeong-Mi, et al.
Publicado: (2021)

Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
por: Kang, Sang Yull, et al.
Publicado: (2018)

Erratum: Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry
por: Kang, Sang Yull, et al.
Publicado: (2019)

Alternative Therapy and Abnormal Liver Function During Adjuvant Chemotherapy in Breast Cancer Patients
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Clinical Outcome of Magnetic Resonance Imaging-Detected Additional Lesions in Breast Cancer Patients
por: Ha, Gi-Won, et al.
Publicado: (2011)

Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma
por: Jung, Seung Pil, et al.
Publicado: (2012)

Clinical Outcomes of Ductal Carcinoma In Situ of the Breast Treated with Partial Mastectomy without Adjuvant Radiotherapy
por: Hwang, Seung Hyun, et al.
Publicado: (2012)

Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstruction
por: Huttunen, Tuomas, et al.
Publicado: (2022)

Prognosis and Sensitivity of Adjuvant Chemotherapy in Mucinous Colorectal Adenocarcinoma without Distant Metastasis
por: Bong, Jun-Woo, et al.
Publicado: (2022)

Primary cutaneous malignant melanoma of the breast
por: Kim, Seon Kwang, et al.
Publicado: (2012)

Prognostic value of admission hyperglycemia on outcomes of thrombolysis in ischemic stroke patients with or without diabetes
por: Fang, Hong-Juan, et al.
Publicado: (2020)

Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy?
por: Lee, Jeonghui, et al.
Publicado: (2011)

Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
por: Esbah, Onur, et al.
Publicado: (2017)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
por: Lee, Kyung-Hun, et al.
Publicado: (2007)

Impact of adjuvant chemotherapy for gliomatosis cerebri
por: Kong, Doo-Sik, et al.
Publicado: (2010)

Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry
por: Kang, Sang Yull, et al.
Publicado: (2020)

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
por: Bianco, A. R., et al.
Publicado: (1991)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139 Cases
por: Kim, Young Wook, et al.
Publicado: (2013)

The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study
por: Jang, Sung Ho, et al.
Publicado: (2018)

Prognostic significance of intraoperative macroscopic serosal invasion finding when it shows a discrepancy in pathologic result gastric cancer
por: Kang, Sang Yull, et al.
Publicado: (2016)

Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy
por: Bennedsgaard, Kristine, et al.
Publicado: (2020)

Breast Cancer Statistics in Korea, 2018
por: Kang, Sang Yull, et al.
Publicado: (2021)

Actual compliance to adjuvant chemotherapy in gastric cancer
por: Kim, Dong-Wook, et al.
Publicado: (2019)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy
por: An, Min Sung, et al.
Publicado: (2015)

Hepatitis B Reactivation During Adjuvant Anthracycline-Based Chemotherapy in Patients with Breast Cancer: A Single Institution's Experience
por: Kim, Min Kyoung, et al.
Publicado: (2007)

Update on Adjuvant Chemotherapy for Early Breast Cancer
por: Rampurwala, Murtuza M, et al.
Publicado: (2014)

Progress in adjuvant chemotherapy for breast cancer: an overview
por: Anampa, Jesus, et al.
Publicado: (2015)

Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
por: Berliere, Martine, et al.
Publicado: (2008)

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel
por: Fountzilas, George, et al.
Publicado: (2012)

Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015)

Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer
por: Starbuck, Kristen D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1jnadg09g1bf5i3abmhv70sk1p